Stanford researchers have developed a device that combines one-photon and two-photon microscopy using fast temporal multiplexing enabling 3D alignment between in vivo and ex vivo data for neuroscience and spatial biology applications.
Antimicrobial peptoids are promising leads for novel antibiotics; however, their activity is often compromised under physiological conditions. Inventors at Stanford enhanced the efficacy of antimicrobial peptoids by using thiourea and thiourea derivatives.
Stanford researchers in the Swartz lab have developed a method for improving the productivity of biosynthetic processes via enzymatic detoxification of aberrant forms of NAD(P)H.
Stanford inventors have developed a cell-free method for carbon-negative biosynthetic production of commodity biochemicals by using hydrogen gas as a source of reducing equivalents.
Stanford researchers in the Swartz lab have proposed a method to synthesize metabolic cofactors from inexpensive substrates for protein synthesis and commodity production applications.
Using advances in flexible electronics, researchers at Stanford have developed a stretchable strain sensor for monitoring solid tumor size progression on or near the skin in real time.
Ultrasound technology is a safe, high-resolution, and cost-efficient tool for imaging. Other modalities, such as MRI or CT, may require the use of anesthesia. This makes it difficult to image pediatric patients and patients sensitive to anesthesia.
Researchers at Stanford have developed a probe, NIRDye812, which improves contrast between healthy and diseased tissues for fluorescence-guided cancer surgery applications.
A team of Stanford researchers has invented a product that can be used to provide relief to patients with hyperhidrosis (excessive sweating), with a particular focus on palmar hyperhidrosis (excessive sweating of the hands).
Stanford inventors have developed and fabricated biodegradable and biocompatible polysaccharide hydrogel optical fibers for fiber optic sensing and light transmission in biomedical applications like antigen detection, tracking cellular events, and optogenetics.
Determining a patient's drug susceptibility is currently a lengthy process requiring hundred to millions of cells. Currently, these cells are labelled, frozen or otherwise manipulated in ways that prevent sequential testing against multiple drugs on the same few cells.